Literature DB >> 16530540

Phospholipid in UC: novel, safe and works--is it too good to be true?

Nick M Croft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16530540     DOI： 10.1053/j.gastro.2005.11.054

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  3 in total

1.  Separate basolateral and apical phosphatidylcholine secretion routes in intestinally differentiated tumor cells.

Authors:  Daniel Gotthardt; Annika Braun; Anke Tietje; Karl Heinz Weiss; Robert Ehehalt; Wolfgang R Stremmel
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

2.  First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses.

Authors:  Max Karner; Andreas Kocjan; Juergen Stein; Stefan Schreiber; Georg von Boyen; Peter Uebel; Carsten Schmidt; Limas Kupcinskas; Ion Dina; Frank Zuelch; Gerhard Keilhauer; Wolfgang Stremmel
Journal:  Am J Gastroenterol       Date:  2014-05-06       Impact factor: 10.864

Review 3.  Ulcerative colitis: understanding its cellular pathology could provide insights into novel therapies.

Authors:  Amandip Kaur; Paraskevi Goggolidou
Journal:  J Inflamm (Lond)       Date:  2020-04-21       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.